Home » Alkermes Sees Chance to Reinvent Vivitrol Drug
Alkermes Sees Chance to Reinvent Vivitrol Drug
If you had polled Wall Street a few months ago about Alkermes Inc.’s naltrexone injection (Vivitrol), you would have heard a number of things — mostly not good.
boston
boston
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May